Article Impact Level: HIGH Data Quality: STRONG Summary of European Journal of Preventive Cardiology https://doi.org/10.1093/eurjpc/zwaf270 Dr. Muhammad Zubair Israr et al.
Points
- Researchers developed an algorithm that uses gut microbiome data to classify heart failure patients as high or low risk for being readmitted to the hospital or dying early.
- The study found that patients with unhealthy gut biomarkers were eight percent more likely to experience death or readmission within the first twelve months following their initial hospital discharge.
- Analysis of over two thousand patients showed that blood levels of chemicals like gamma-butyrobetaine were significantly higher in individuals consuming diets high in red meat and eggs.
- The new risk calculator demonstrated superior long term accuracy by predicting patient outcomes for up to one year while most current clinical tools only provide a thirty day estimate.
- This research highlights the importance of the gut-heart axis and suggests that managing microbial health through diet could potentially improve survival rates for patients with advanced heart failure.
Summary
This research evaluated the development and validation of a novel risk stratification algorithm for heart failure (HF) that incorporates gut microbiome-derived metabolites. While current clinical risk calculators typically focus on short-term 30-day outcomes using standard metrics, this study sought to address the long-term impact of multimorbidity and the gut-heart axis. The investigation utilized data from 2,071 patients across 12 European countries, tracking outcomes for 12 months following hospital admission. By measuring blood levels of gut-related chemicals such as gamma-butyrobetaine and acetyl-L-carnitine, researchers identified a distinct link between microbial activity and adverse cardiovascular events.
The study findings demonstrated that patients with biomarkers indicative of an unhealthy gut were 8% more likely to die or be readmitted to the hospital within the first year of follow-up. The integrated algorithm, which utilizes 11 distinct factors including age, diabetes, COPD, and prior hospitalizations, successfully classified patients into high, intermediate, and low-risk categories. Notably, the survival rate among individuals categorized as low-risk was approximately twice as high as that of the high-risk group. This inclusion of microbial metabolites significantly improved the model’s ability to predict clinical deterioration up to one year, surpassing the utility of traditional calculators.
These results suggest that the gut microbiome serves as a potent influence on cardiovascular health and a critical component of HF pathophysiology. Elevated levels of metabolites produced by bacteria that thrive on Western-style diets were directly correlated with increased mortality and hospitalization risks. The researchers hope that this new predictive tool can be integrated into future management guidelines to help clinicians identify patients requiring more intensive support. Furthermore, the study raises the potential for dietary interventions and probiotics to serve as therapeutic strategies to improve outcomes by modulating the gut-heart axis in multimorbid patients.
Link to the article: https://academic.oup.com/eurjpc/article/33/2/202/8121317?login=false
References
Israr, M. Z., Salzano, A., Zhan, H., Voors, A. A., Ng, L. L., & Suzuki, T. (2026). Risk calculator of multimorbid risk of rehospitalization and death from heart failure: Including the contribution of the gut microbiome. European Journal of Preventive Cardiology, 33(2), 202–211. https://doi.org/10.1093/eurjpc/zwaf270
